Nasdaq28d
X4 Pharmaceuticals Enters Exclusive Licensing Agreement with Norgine, Securing Up to €226 Million in Milestone Payments for Mavorixafor
X4 Pharmaceuticals secures €28.5 million upfront and potential €226 million in milestone payments from Norgine for mavorixafor commercialization. X4 Pharmaceuticals has entered an exclusive ...
Business Insider28d
X4, Norgine enter exclusive licensing agreement for mavorixafor
X4 Pharmaceuticals (XFOR) and Norgine announced that they have entered into an exclusive licensing and supply agreement under which Norgine will commercialize mavorixafor in Europe, Australia ...
Yahoo Finance28d
X4 Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize Mavorixafor in Europe, Australia, and New Zealand
“We believe Norgine to be the ideal partner due to their impressive infrastructure and successful commercialization track record in specialty pharmaceuticals, as well as a shared focus on ...
Radar on MSN4mon
Good news as food hygiene ratings awarded to three Caerphilly establishments
Just Perfect Catering @ Norgine Ltd at Tir-Y-Berth Industrial Estate, Tir-Y-Berth, Hengoed; rated on September 19 Pubs, bars ...
Stockhouse28d
X4 Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize Mavorixafor in Europe, Australia, and New Zealand
“We believe Norgine to be the ideal partner due to their impressive infrastructure and successful commercialization track record in specialty pharmaceuticals, as well as a shared focus on putting ...